Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: J Gene Med. 2010 Jun;12(6):538–544. doi: 10.1002/jgm.1466

Figure 2. Pancreas tissue from BB DR+/+wild type, GLP-1 treated and untreated BB DR.lyp/lyp rats.

Figure 2

Pancreas sections were stained for insulin (a-d) and glucagon (e-h). Untreated BB DR+/+ wild type control rat (panels a/e); untreated BB DR.lyp/lyp rat at diabetes onset (panels b/f) and at 5 days post diabetes onset (panels c/g) and GLP-1 treated female BB DR.lyp/lyp rat at 143 days of age (panels d/h). Untreated BB DR.lyp/lyp control rats received daily insulin from 40 days of age to prevent hyperglycemia, severe weight loss and preserve health. Magnification 20x.